BioCorneum debuts bruise recovery system amid growing cosmetic procedure market

BioCorneum has unveiled a dual-action Bruise Care System, designed to prepare patients and support bruise and scar recovery after cosmetic and surgical procedures, such as Botox, liposuction, sclerotherapy, and dermal fillers.

The product consists of a two-pronged approach to scar care. The advanced bruise cream uses a proprietary formula designed to accelerate healing and reduce bruising. It functions by supporting circulation and reducing inflammation and can be used before and after treatment. 

The advanced bruise dietary supplement can also be used pre- and post-procedure. It is primarily made up of natural ingredients, including arnica and acerola extracts, bromelain, and vitamin K2. It functions by encouraging circulation and maintaining skin integrity. 

The bruise system is offered through practitioners and is available directly to consumers via online channels.

“This innovation was developed to empower both patients and practitioners in optimizing healing outcomes with trusted, evidence-based formulas,” says Kristy Matus, VP of Product Management at BioCorneum.

Safety in free market injectables 

The BioCorneum bruise system is an addition to a rapidly growing market for cosmetic procedures. 

The International Society of Aesthetic Plastic Surgery reports that surgical and non-surgical cosmetic procedures increased by 42.5% between 2020 and 2024. Additionally, Innova Market Insights data indicates that 33% of consumers worldwide consider anti-aging the most crucial function of skin care. This has led to a 5% increase in global product launches with anti-aging claims between 2019 and 2023.

Anti-aging cosmetic procedures are diversifying into injectables. As the portfolio of minimally invasive anti-aging procedures continues to grow, there is a cultural shift toward non-surgical interventions. BioCorneum launches a bruise recovery system, expanding the growing cosmetic procedure market.

Personal Care Insights previously reported on the popularization of the “liquid face lift” — clinical injectable treatments such as fillers and biostimulators that achieve a lifted look without surgery. This popularization was attributed to normalization via influencers and celebrity culture.

The societal shift toward destigmatizing cosmetic and anti-aging procedures is driving greater transparency, building consumer trust, and increasing demand for non-surgical procedures. The market is experiencing innovations alongside this growth. In December 2025, research presented at the Radiological Society of North America indicated that ultrasound guidance can reduce the risk of complications at injection sites with higher vascular complexity by increasing precision.

However, the popularization and the accessibility of minimally invasive interventions are also creating “unrealistic expectations, filtered beauty standards, and a rise in ‘DIY’ treatments promoted by unqualified influencers,” Dr. Manav Bawa, medical director of Time Clinic & Trainer on behalf of Allergan Aesthetics, previously told Personal Care Insights.

The US Food and Drug Administration recently issued warnings to 18 website owners for illegally marketing unapproved and misbranded botulinum toxin products commonly known as Botox. Unapproved Botox poses serious health risks and can cause botulism-like symptoms.

The increase in demand for minimally invasive procedures and injectables is simultaneously fostering a market that encourages innovation and refinement while experiencing oversaturation and difficulties with regulation, posing risks to health and safety.